Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Income from Non-Controlling Interests (2022 - 2024)

Moolec Science (MLECW) posted Income from Non-Controlling Interests of -$2.3 million for Q4 2024, down 61.49% sequentially from -$1.4 million in Q3 2024, and up 14.71% YoY from -$2.0 million in Q1 2024.

Moolec Science (MLECW) Income from Non-Controlling Interests (2022 - 2024) Analysis & Trends

Moolec Science has reported Income from Non-Controlling Interests for 3 years, with the latest figure at -$2.3 million in Q4 2024.

  • Quarterly Income from Non-Controlling Interests rose 14.71% year-over-year to -$2.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.1 million (down 95.24% YoY) and the FY2024 annual result came in at $107597.0, up 494.06% from the prior year.
  • Income from Non-Controlling Interests eased to -$2.3 million in Q4 2024 per MLECW's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $49.1 million in Q2 2023 and troughed at -$48.0 million in Q4 2022.
  • A 3-year average of $41430.3 and a median of -$358578.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
  • The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests slumped 324.79% in 2023, then soared 336.35% in 2024.
  • Over 3 years, Income from Non-Controlling Interests stood at -$48.0 million in 2022, then soared by 94.44% to -$2.7 million in 2023, then grew by 14.71% to -$2.3 million in 2024.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$2.3 million, -$1.4 million, and $5.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 63.60 Mn
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.27 Mn
Sep 30, 2024 -1.41 Mn
Jun 30, 2024 4.95 Mn
Mar 31, 2024 847,485.00
Dec 31, 2023 -2.67 Mn
Sep 30, 2023 -1.62 Mn
Jun 30, 2023 49.06 Mn
Mar 31, 2023 -358,578.00
Dec 31, 2022 -47.96 Mn
Sep 30, 2022 721,426.00
Mar 31, 2022 1.17 Mn